US FDA clears Globus Medical’s Excelsius GPS robotic system


The Excelsius GPS robotic guidance and navigation system from Globus Medical has been 510(k) cleared by the US Food and Drug Administration (FDA).

The robotic system received CE mark in January of this year.

This platform technology is designed to support minimally invasive and open orthopaedic and neurosurgical procedures, with screw placement applications in spine and orthopaedic surgery. Excelsius GPS integrates Globus Medical implants and instruments and is compatible with pre-operative CT, intra-operative CT and fluoroscopic imaging modalities. The system is designed to minimise radiation exposure, streamline workflow, and reproducibly assist in implant placement.

Globus Medical has been expanding its focus on robotic technology, recently acquiring KB Medical. This Lausanne, Switzerland-based company developed a hardware and software robotic platform designed to enable unique intraoperative haptic steering capability. The AQrate system received CE mark in June 2016.


Please enter your comment!
Please enter your name here